Sorrento Therapeutics, Inc. — Form D

Sorrento Therapeutics, Inc. of San Diego, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-01-11. The offering totals $2.0M, of which $2.0M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (29)

Showing 25 of 29 people.

NameRoleLocation
Glenn L HalprynDirectorIrvine, CA
Jane H Hsiao, Ph.D., MBADirectorSan Diego, CA
Kim H Janda, Ph.D.DirectorSan Diego, CA
Henry Ji, Ph.D.DirectorSan Diego, CA
Curtis L Lockshin, Ph.D.DirectorSan Diego, CA
Henry Ji, Ph.D.Executive OfficerSan Diego, CA
Henry JiDirectorPalo Alto, CA
Henry JiExecutive OfficerPalo Alto, CA
Antonius SchuhDirectorSan Diego, CA
Antonius SchuhExecutive OfficerSan Diego, CA
Curtis LockshinDirectorFramingham, MA
Ernst-Guenter AftingDirectorLos Altos, CA
Lewis J ShusterDirectorSan Diego, CA
Cam G GallagherDirectorSan Diego, CA
Richard G VincentDirectorSan Diego, CA
Richard G VincentExecutive OfficerSan Diego, CA
Emst-Gunter G AftingDirectorSan Diego, CA
Voung M Dr. TrieuDirectorSan Diego, CA
Voung M Dr. TrieuExecutive OfficerSan Diego, CA
Jaisim M ShahDirectorSan Diego, CA
David G WebbDirectorSan Diego, CA
Kim G JandaDirectorSan Diego, CA
Scott M SalkaDirectorSan Diego, CA
George M UyExecutive OfficerSan Diego, CA
Kim D JandaDirectorSan Diego, CA

Other filings by this issuer (4)

FiledFormOfferingSold
2013-10-22D$1.9M$1.9M
2013-03-28D$10.0M$6.4M
2009-09-24D$7.5M$7.5M
2009-09-24D$2.0M$2.0M

More